NIH Clinical Trial Evaluating Mixed COVID-19 Vaccine Schedules Begins
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19…